###begin article-title 0
Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)
###end article-title 0
###begin p 1
###xml 541 543 541 543 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 984 987 972 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 1127 1130 1115 1118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 1162 1165 1150 1153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 1222 1225 1210 1213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 1293 1296 1281 1284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 1426 1429 1414 1417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 1476 1479 1464 1467 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 1829 1830 1817 1818 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
mTOR (mammalian target of rapamycin) stimulates cell growth by phosphorylating and promoting activation of AGC (protein kinase A/protein kinase G/protein kinase C) family kinases such as Akt (protein kinase B), S6K (p70 ribosomal S6 kinase) and SGK (serum and glucocorticoid protein kinase). mTORC1 (mTOR complex-1) phosphorylates the hydrophobic motif of S6K, whereas mTORC2 phosphorylates the hydrophobic motif of Akt and SGK. In the present paper we describe the small molecule Ku-0063794, which inhibits both mTORC1 and mTORC2 with an IC50 of approximately10 nM, but does not suppress the activity of 76 other protein kinases or seven lipid kinases, including Class 1 PI3Ks (phosphoinositide 3-kinases) at 1000-fold higher concentrations. Ku-0063794 is cell permeant, suppresses activation and hydrophobic motif phosphorylation of Akt, S6K and SGK, but not RSK (ribosomal S6 kinase), an AGC kinase not regulated by mTOR. Ku-0063794 also inhibited phosphorylation of the T-loop Thr308 residue of Akt phosphorylated by PDK1 (3-phosphoinositide-dependent protein kinase-1). We interpret this as implying phosphorylation of Ser473 promotes phosphorylation of Thr308 and/or induces a conformational change that protects Thr308 from dephosphorylation. In contrast, Ku-0063794 does not affect Thr308 phosphorylation in fibroblasts lacking essential mTORC2 subunits, suggesting that signalling processes have adapted to enable Thr308 phosphorylation to occur in the absence of Ser473 phosphorylation. We found that Ku-0063794 induced a much greater dephosphorylation of the mTORC1 substrate 4E-BP1 (eukaryotic initiation factor 4E-binding protein 1) than rapamycin, even in mTORC2-deficient cells, suggesting a form of mTOR distinct from mTORC1, or mTORC2 phosphorylates 4E-BP1. Ku-0063794 also suppressed cell growth and induced a G1-cell-cycle arrest. Our results indicate that Ku-0063794 will be useful in delineating the physiological roles of mTOR and may have utility in treatment of cancers in which this pathway is inappropriately activated.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 495 496 495 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 497 498 497 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 583 584 583 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 835 836 835 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 837 838 837 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 950 951 950 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 973 974 973 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 975 977 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1102 1104 1102 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1219 1221 1219 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1222 1224 1222 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
The mTOR (mammalian target of rapamycin) protein kinase lies at the nexus of signalling pathways that regulate cell growth and proliferation. Many cancer-driving mutations in genes such as receptor tyrosine kinases, Ras, PI3K (phosphoinositide 3-kinase) and PTEN (phosphatase and tensin homologue deleted on chromosome 10) stimulate proliferation, growth and survival by activating mTOR kinase. Two mTOR complexes have been characterized, termed mTORC1 (mTOR complex-1) and mTORC2 (reviewed in [1,2]). mTORC1 consists of mTOR, Raptor and mLST8 and is acutely inhibited by rapamycin [3-5]. mTORC1 is activated by insulin and growth factors via a PI3K-controlled pathway, involving Akt-mediated phosphorylation of PRAS40 (proline-rich Akt substrate of 40 kDa) and tuberous sclerosis complex-2 protein, and activation of the Rheb GTPase [6,7]. mTORC1 is also stimulated by amino acids through a pathway involving bidirectional transport of amino acids [8] and the Rag GTPase [9,10]. Low-energy conditions suppress cell growth by inhibiting mTORC1 via the LKB1-AMPK (AMP-activated protein kinase) pathway [11]. mTORC2 consists of mTOR, Rictor, Sin1, mLST8 as well as Protor and is insensitive to acute rapamycin treatment [12-18]. The activity of mTORC2 activity is controlled by PI3K, but is insensitive to amino acids or energy stress.
###end p 3
###begin p 4
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 724 725 724 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 726 727 726 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 791 793 791 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 801 803 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 837 839 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1040 1042 1040 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1043 1045 1043 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1151 1152 1151 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1152 1153 1152 1153 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1335 1338 1335 1338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 1348 1350 1348 1350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1351 1353 1351 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1565 1567 1565 1567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1568 1570 1568 1570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1907 1908 1907 1908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 1909 1910 1909 1910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1913 1915 1913 1915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 1927 1930 1927 1930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28a">28a</xref>
###xml 2155 2163 2155 2163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2168 2175 2168 2175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
A key role of mTOR complexes is to phosphorylate and control the activity of a subgroup of related AGC (protein kinase A/protein kinase G/protein kinase C) family kinases that comprise isoforms of Akt, S6K (p70 ribosomal S6 kinase), PKC (protein kinase C) and SGK (serum and glucocorticoid protein kinase). mTOR complexes phosphorylate these enzymes at a conserved C-terminal non-catalytic residue, termed the 'hydrophobic motif'. Activation of AGC kinases also requires phosphorylation of an additional site within their kinase catalytic domain termed the 'T-loop motif'. This phosphorylation is executed by the PDK1 (3-phosphoinositide-dependent protein kinase-1) [19]. mTORC1 phosphorylates the hydrophobic motif of S6K [4,5], whereas mTORC2 phosphorylates the hydrophobic motifs of Akt [20], SGK [21] and certain isoforms of PKC [17,22]. In the case of S6K, SGK and PKC isoforms, hydrophobic motif phosphorylation creates a high-affinity docking site for PDK1, thereby promoting phosphorylation and activation of these enzymes by PDK1 [19,23]. In the case Akt, interaction of the PH (pleckstrin homology) domains in PDK1 and Akt with PtdIns(3,4,5)P3 (a product of PI3K activation), at the plasma membrane of cells, brings these enzymes together and induces a conformational change in Akt that enables it to be phosphorylated at Thr308 by PDK1 [24,25]. Recent data also indicates that mTORC2 controls the phosphorylation of Akt and PKC isoforms at a conserved phosphorylation site termed the 'turn motif' that stabilizes these enzymes in an active conformation [26,27]. mTORC1 also phosphorylates other substrates such as the eukaryotic translation initiation factor 4E-BP1 [eIF4E (eukaryotic initiation factor 4E)-binding protein 1]. Phosphorylation of 4E-BP1 by mTOR induces dissociation from eIF4E, promoting initiation of protein translation that is required to power cell growth and proliferation ([4,5],[28], but see [28a]). In the present study, we describe the characterization of Ku-0063794, a novel potent and highly specific small-molecule inhibitor of the mTOR protein kinase. We demonstrate that Ku-0063794 inhibits both mTORC1 and mTORC2 in vitro and in vivo and can be employed to dissect cellular functions of the mTOR pathway.
###end p 4
###begin title 5
MATERIALS AND METHODS
###end title 5
###begin title 6
Materials
###end title 6
###begin p 7
###xml 94 96 90 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 493 496 489 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 506 509 502 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 581 583 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 714 717 710 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 728 731 724 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 773 775 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 900 903 896 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 912 915 908 911 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 957 959 953 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 525 530 <span type="species:ncbi:10090">mouse</span>
Protein G-Sepharose and glutathione-Sepharose were purchased from Amersham Bioscience. [gamma-32P]ATP was from PerkinElmer; IGF1 (insulin-like growth factor) was from Invitrogen. Tween 20, DMSO, PMA and dimethyl pimelimidate were from Sigma, and CHAPS and rapamycin were from Calbiochem. Akti-1/2, PI-103 and PD0325901-CL were synthesized by Dr Natalia Shpiro at the MRC Protein Phosphorylation Unit, University of Dundee. Ku-0063794 was synthesized at AstraZeneca. The wild-type control mLST8+/+ and mLST8-/- knockout MEFs (mouse embryonic fibroblasts) were described previously [17] and provided by David Sabatini (Whitehead Institute for Biomedical Research, Cambridge, MA, U.S.A.). The wild-type control Rictor+/+ and Rictor-/- knockout MEFs were described previously [29] and provided by Mark Magnuson (Vanderbilt University School of Medicine, Nashville, TN, U.S.A.). The wild-type control Sin1+/+ and Sin1-/- knockout MEFs were described previously [16] and provided by Bing Su (Yale University School of Medicine, New Haven, CT, U.S.A.).
###end p 7
###begin title 8
Antibodies
###end title 8
###begin p 9
###xml 116 118 116 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 194 210 194 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 259 261 259 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 393 395 393 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 568 570 568 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 669 671 669 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 746 753 746 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 793 794 793 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 837 839 837 839 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 1023 1026 1023 1026 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">346</sup>
###xml 1031 1034 1031 1034 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">356</sup>
###xml 1042 1045 1042 1045 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">366</sup>
###xml 1055 1057 1055 1057 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 1255 1257 1255 1257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 1383 1385 1383 1385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 1512 1514 1512 1514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 1623 1625 1623 1625 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 1770 1773 1770 1773 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">246</sup>
###xml 1783 1785 1783 1785 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 1934 1936 1934 1936 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 2065 2067 2065 2067 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 2214 2217 2211 2214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">227</sup>
###xml 2380 2383 2377 2380 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">422</sup>
###xml 2405 2408 2402 2405 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">389</sup>
###xml 2537 2540 2534 2537 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">422</sup>
###xml 2550 2552 2547 2549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 2574 2577 2571 2574 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 2590 2593 2587 2590 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 2606 2609 2603 2606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">450</sup>
###xml 2634 2637 2631 2634 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">389</sup>
###xml 2679 2682 2676 2679 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">235</sup>
###xml 2768 2770 2765 2767 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">37</sup>
###xml 2774 2776 2771 2773 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">46</sup>
###xml 2804 2806 2801 2803 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">65</sup>
###xml 2871 2874 2868 2871 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">202</sup>
###xml 2878 2881 2875 2878 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">204</sup>
###xml 2925 2928 2922 2925 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">573</sup>
###xml 2953 2956 2950 2953 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">380</sup>
###xml 2986 2991 2983 2988 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">24/32</sup>
###xml 3027 3029 3017 3019 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">21</sup>
###xml 3033 3034 3023 3024 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 3064 3068 3054 3058 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2481</sup>
###xml 3101 3105 3091 3095 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2448</sup>
###xml 3328 3330 3318 3320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 40 45 <span type="species:ncbi:9940">sheep</span>
###xml 149 154 <span type="species:ncbi:9606">human</span>
###xml 194 210 <span type="species:ncbi:562">Escherichia coli</span>
###xml 286 291 <span type="species:ncbi:9606">human</span>
###xml 420 425 <span type="species:ncbi:9606">human</span>
###xml 487 492 <span type="species:ncbi:9606">human</span>
###xml 595 600 <span type="species:ncbi:10090">mouse</span>
###xml 702 707 <span type="species:ncbi:9606">human</span>
###xml 746 753 <span type="species:ncbi:562">E. coli</span>
###xml 859 864 <span type="species:ncbi:9940">sheep</span>
###xml 1287 1292 <span type="species:ncbi:9606">human</span>
###xml 1411 1416 <span type="species:ncbi:9606">human</span>
###xml 1653 1658 <span type="species:ncbi:9606">human</span>
###xml 1836 1841 <span type="species:ncbi:9606">human</span>
###xml 1964 1969 <span type="species:ncbi:9606">human</span>
###xml 2087 2092 <span type="species:ncbi:9940">sheep</span>
###xml 3435 3446 <span type="species:ncbi:3704">horseradish</span>
The following antibodies were raised in sheep and affinity-purified on the appropriate antigen: anti-mLST8 (S837B, 3rd bleed) was raised against the human full-length mLST8 protein expressed in Escherichia coli (used for immunoblotting), anti-Raptor (S682B, 3rd bleed; residues 1-20 of human Raptor, MESEMLQSPLLGLGEEDEAD, used for immunoblotting and immunoprecipitation), anti-Rictor (S654B, 3rd bleed; residues 6-20 of human Rictor, RGRSLKNLRVRGRND, used for immunoblotting in HEK-293 (human embryonic kidney 293) cells and immunoprecipitation), anti-Rictor (S274C, 1st bleed; residues 6-20 of mouse Rictor, RGRSLKNLRIRGRND, used for immunoblotting), anti-Sin1 (S8C, 1st bleed) was raised against the human full-length Sin1 protein expressed in E. coli (used for immunoblotting). Anti-NDRG1 (N-Myc downstream-regulated gene-1) (S276B, 2nd bleed) was made in sheep using recombinant GST (glutathione transferase) fusion of full-length NDRG1 (used for immunoblotting). An antibody that recognizes NDRG1 phosphorylated at Thr346, Thr356 and Thr366 (S911B, 2nd bleed; termed pNDRG1 3xThr-P) was raised against the nonapeptide RSRSHpTSEG, whose sequence is common to all three SGK1 phosphorylation sites on NDGR1 (used for immunoblotting). Anti-Akt1 (S695B, 3rd bleed; residues 466 - 480 of human Akt1 RPHFPQFSYSASGTA, used for immunoblotting and immunoprecipitation), anti-S6K (S417B, 2nd bleed; residues 25-44 of human S6K, AGVFDIDLDQPEDAGSEDEL, used for immunoblotting and immunoprecipitation). Anti-GST (S902A, 1st bleed) was raised against the GST tag expressed from pGex4T (used for immunoblotting). Anti-PRAS40 (S115B, 1st bleed; residues 238-256 of human PRAS40, DLPRPRLNTSDFQKLKRKY, used for immunoblotting). An antibody that recognizes PRAS40 phosphorylated at Thr246 (S114B, 2nd bleed) was raised against the residues 240-251 of human PRAS40, CRPRLNTpSDFQK (used for immunoblotting). Anti-RSK2 (ribosomal S6 kinase 2) (S382B, 1st bleed; residues 712-734 of human RNQSPVLEPVGRSTLAQRRGIKK, used for immunoblotting and immunoprecipitation); Anti-FoxO1 (S504A, 1st bleed) was made in sheep using recombinant GST-fusion FoxO1 (2-655, used for immunoblotting). Anti-beta-tubulin (H-235, #sc-9104), phospho-RSK Thr227 (#sc-12445-R) and the total mTOR antibody (#sc-1549) were purchased from Santa Cruz Biotechnology. For phospho-immunoblotting of the hydrophobic motif of SGK1(Ser422), we employed the Thr389 S6K antibody (# 9205) from Cell Signaling Technology, which we previously demonstrated cross-reacted with the phosphorylated Ser422 of SGK1 [30]. The phospho-Akt Ser473 (#9271), Thr308 (#4056), Thr450 (#9267), phospho-S6K Thr389 (#9234), phospho S6 ribosomal protein Ser235 (#4856), total S6 ribosomal protein (#2217), 4E-BP1 total (#9452), phospho 4E-BP1 Thr37/Thr46 (#9459), phospho 4E-BP1 Ser65 (#9451), phospho-ERK (extracellular-signal-regulated kinase) Thr202/Tyr204 (#9101), total ERK (#9102), phospho-RSK Thr573 (#9346), phospho-RSK Thr380 (#9341), phospho-FoxO1/O3 Thr24/32 (#9464), phospho-GSK3alpha/beta Ser21/Ser9 (#9331), the phospho-mTOR Ser2481 (#2974) and the phospho-mTOR Ser2448 (#2971) were purchased from Cell Signaling Technology. For phospho-immunoblotting of the phosphorylated T-loop of S6K, we employed the pan-PDK1 site antibody from Cell Signaling Technology (#9379) as previously described [31].The GSK3alpha/beta antibody (44-610) was purchased from Biosource. The secondary antibodies coupled to horseradish peroxidase used for immunoblotting were obtained from Thermo Scientific.
###end p 9
###begin title 10
General methods
###end title 10
###begin p 11
###xml 208 215 208 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 775 777 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 812 813 807 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 813 814 808 809 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 854 856 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 208 215 <span type="species:ncbi:562">E. coli</span>
Tissue culture, immunoblotting, restriction enzyme digests, DNA ligations and other recombinant DNA procedures were performed using standard protocols. DNA constructs used for transfection were purified from E. coli DH5alpha using Qiagen plasmid Mega or Maxi kits according to the manufacturer's protocol. All DNA constructs were verified by DNA sequencing, which was performed by The Sequencing Service, School of Life Sciences, University of Dundee, Dundee, U.K., using DYEnamic ET terminator chemistry (Amersham Biosciences) on Applied Biosystems automated DNA sequencers. For transfection studies, typically ten 10-cm-diameter dishes of HEK-293 cells were cultured, and each dish was transfected with 5-10 mug of the indicated plasmids using the polyethylenimine method [32]. Cellular levels of PtdIns(3,4,5)P3 were measured as described previously [33]. MEFs were cultured with additional non-essential amino acids and 1% sodium pyruvate solution.
###end p 11
###begin title 12
Buffers
###end title 12
###begin p 13
The following buffers were used: Tris lysis buffer [50 mM Tris/HCl, pH 7.5, 1 mM EGTA, 1 mM EDTA, 0.3% (w/v) CHAPS, 1 mM sodium orthovanadate, 10 mM sodium beta-glycerophosphate, 50 mM sodium fluoride, 5 mM sodium pyrophosphate, 0.27 M sucrose, 0.15 M NaCl, 0.1% (v/v) 2-mercaptoethanol, 1 mM benzamidine and 0.1 mM PMSF], Buffer A [50 mM Tris/HCl, pH 7.5, 0.1 mM EGTA and 0.1% (v/v) 2-mercaptoethanol], Hepes lysis buffer [40 mM Hepes, pH 7.5, 120 mM NaCl, 1 mM EDTA, 0.3% (w/v) CHAPS, 10 mM sodium pyrophosphate, 10 mM sodium beta-glycerophosphate, 50 mM sodium fluoride, 0.5 mM sodium orthovanadate, 1 mM benzamidine and 0.1 mM PMSF], Hepes kinase buffer (25 mM Hepes, pH 7.5, 50 mM KCl and TBS-Tween Buffer [50 mM Tris/HCl, pH 7.5, 0.15 M NaCl and 0.1% (v/v) Tween 20] and Sample Buffer [50 mM Tris/HCl, pH 6.8, 6.5% (v/v) glycerol, 1% (w/v) SDS and 1% (v/v) 2-mercaptoethanol].
###end p 13
###begin title 14
Cell lysis
###end title 14
###begin p 15
###xml 270 271 270 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 270 271 270 271 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>g</italic></bold>
###xml 15 20 <span type="species:ncbi:9606">human</span>
HEK-293, HeLa (human cervical carcinoma) or MEF cells were cultured and treated as described in the Figure legends. Following treatment, cells were rapidly rinsed twice with ice-cold PBS and then lysed using Tris lysis buffer. Whole-cell lysates were centrifuged (18000 g at 4 degreesC for 20 min), supernatants were removed and stored in aliquots at -80 degreesC until required.
###end p 15
###begin title 16
Specificity kinase panel
###end title 16
###begin p 17
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 488 495 482 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 571 573 561 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sup>
###xml 1255 1256 1176 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 1256 1257 1177 1178 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 1283 1285 1204 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
All assays were performed at The National Centre for Protein Kinase Profiling () as previously described [34]. Briefly, all assays were carried out robotically at room temperature (21 degreesC) and were linear with respect to time and enzyme concentration under the conditions used. Assays were performed for 30 min using Multidrop Micro reagent dispensers (Thermo Electron Corporation, Waltham, MA, U.S.A.) in a 96-well format. The abbreviations for each kinase are defined in legend to Table 1. The concentration of magnesium acetate in the assays was 10 mM and [gamma-33P]ATP (approximately800 c.p.m./pmol) was used at 5 muM for CK2alpha, DYRK3, EF2K, ERK1, ERK8, GSK3beta, HIPK2, IGF1R, IRR, MARK3, MKK1, p38gamma MAPK (mitogen-activated protein kinase), p38delta MAPK, PAK4, PIM2, Akt1, PLK1, PKCzeta and PRK2; 20 muM for CaMKKbeta, CDK2/cyclin A, CHK1, CHK2, CK1delta, CSK, EPH-B3, FGF-R1, IR, JNK1alpha1, JNK2alpha2, MAPKAP-K2, MSK1, MST2, MST4, p38beta MAPK, PKA, PAK5, PAK6, PDK1, PIM1, PIM3, PKCalpha, ROCKII, PRAK, S6K1, SGK1, SYK, VEGFR and YES1; or 50 muM for AMPK, BRSK2, BTK, CaMK1, DYRK1a, DYRK2, EPH-A2, ERK2, IKKepsilon, LCK, MELK, NEK2A, NEK6, p38alpha, PhKgamma1, Akt2, PKD1, RSK1, RSK2, SRPK1 and TBK1, in order to be at or below the Km for ATP for each enzyme [34].
###end p 17
###begin title 18
Effect of Ku-0063794 on 76 protein kinases
###end title 18
###begin p 19
###xml 1365 1385 1359 1379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aspergillus nidulans</italic>
###xml 1365 1385 <span type="species:ncbi:162425">Aspergillus nidulans</span>
###xml 1508 1514 <span type="species:ncbi:10090">murine</span>
Results are presented as percentage of kinase activity compared with control incubations, in which Ku-0063794 was omitted. Protein kinases were assayed as described in the Materials and methods section. The results are an average of a triplicate determination+/-S.D. Asterisks indicate inhibition of >2-fold. Abbreviations not defined in main text: BRSK, brain-specific kinase; BTK, Bruton's tyrosine kinase; CaMK1, calmodulin-dependent kinase; CaMKK, CaMK kinase; CDK, cyclin-dependent kinase; CHK, checkpoint kinase; CK1, casein kinase 1; CSK, C-terminal Src kinase; DYRK, dual-specificity tyrosine-phosphorylated and regulated kinase; EF2K, elongation-factor-2 kinase; EPH, ephrin; FGF-R, fibroblast growth factor receptor; GSK3, glycogen synthase kinase 3; HIPK, homeodomain-interacting protein kinase; IGF1R, IGF1 receptor; IKK, inhibitory kappaB kinase; IR, insulin receptor; IRR, insulin-related receptor; JNK, c-Jun N-terminal kinase; Lck, lymphocyte cell-specific protein tyrosine kinase; MAPKAP-K, MAPK-activated protein kinase; MARK, microtubule-affinity-regulating kinase; MELK, maternal embryonic leucine-zipper kinase; MKK1, MAPK kinase-1; MLCK, smooth muscle myosin light-chain kinase; MNK, MAPK-integrating protein kinase; MSK, mitogen- and stress-activated protein kinase; MST, mammalian homologue Ste20-like kinase; NEK, NIMA (never in mitosis in Aspergillus nidulans)-related kinase; PAK, p21-activated protein kinase; PHK, phosphorylase kinase; PIM, provirus integration site for Moloney murine leukaemia virus; PKA, cAMP-dependent protein kinase; PKD, protein kinase D; PLK, polo-like kinase; PRAK, p38-regulated activated kinase; PRK, protein kinase C-related kinase; ROCK, Rho-dependent protein kinase; SRPK, serine-arginine protein kinase; SYK, spleen tyrosine kinase; TBK1, TANK-binding kinase 1; VEGFR, vascular endothelial growth factor receptor; YES1, Yamaguchi sarcoma viral oncogene homologue 1. n.d., not determined.
###end p 19
###begin title 20
Lipid kinase panel
###end title 20
###begin p 21
###xml 117 118 117 118 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 278 279 277 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
SPHK1 (sphingosine kinase 1) was assayed as follows: SPHK1 [diluted in 50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1 mM EGTA and 1 mM DTT (dithiothreitol)] was assayed against sphingosine in a final volume of 50 mul containing 50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1 mM EGTA, 10 muM sphingosine, 10 muM ATP and 1 mM DTT and incubated for 30 min at room temperature.
###end p 21
###begin p 22
###xml 93 94 93 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 236 237 235 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
SPHK2 was assayed as follows: SPHK2 (diluted in 50 mM Tris/HCl, pH 7.5, 200 mM KCl, 5 mM MgCl2, 1 mM EGTA and 1 mM DTT) was assayed against sphingosine in a final volume of 50 mul containing 50 mM Tris/HCl, pH 7.5, 200 mM KCl, 5 mM MgCl2, 1 mM EGTA, 10 muM sphingosine, 1 muM ATP and 1 mM DTT and incubated for 30 min at room temperature.
###end p 22
###begin p 23
###xml 117 118 117 118 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 235 236 234 235 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Choline kinase was assayed as follows: choline kinase (diluted in 25 mM glycine/NaOH, pH 8.5, 67 mM KCl and 5 mM MgCl2) was assayed against choline in a final volume of 50 mul containing 25 mM glycine/NaOH, pH 8.5, 67 mM KCl, 5 mM MgCl2, 1 mM choline, 1 muM ATP and 1 mM DTT and incubated for 30 min at room temperature. These three assays were stopped by addition of 50 mul Kinase Glo Plus Reagent, incubated for 10 min at room temperature and read for 1 s/well.
###end p 23
###begin p 24
###xml 164 165 156 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 165 166 157 158 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 286 287 277 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 319 320 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 320 321 310 311 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 686 687 672 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 687 688 673 674 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Class 1 PI3Kalpha was assayed as follows: PI3Kalpha (diluted in 50 mM Hepes, pH 7.5, 150 mM NaCl, 0.02% sodium cholate and 1 mM DTT) was assayed against PtdIns(4,5)P2 diC8 in a final volume of 50 mul containing 37 mM Hepes, pH 7.5, 111 mM NaCl, 0.02% sodium cholate, 5 mM DTT, 5 mM MgCl2, 1 mM ATP and 2 muM PtdIns(4,5)P2 and incubated for 70 min at room temperature. Assays were stopped by addition of a 5.5 mul solution of 50 mM EDTA and 0.02% (w/v) sodium cholate. An aliquot (25 mul) of the resultant mixture was transferred to a Lumitrac 200 plate. Detection mix 1 [41 mM Hepes, pH 7.5, 123 mM NaCl, 1.7 mug GST-GRP1 (guanine-nucleotide-releasing protein 1), 0.16 muM PtdIns(3,4,5)P3-biotin, 1.6 mug streptavidin-allophycocyanin and 0.96 mug/ml europium-chelatelabelled antibody] was added to give a final volume of 50 mul and incubated for 20 min at room temperature before reading.
###end p 24
###begin p 25
###xml 162 163 156 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 163 164 157 158 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 284 285 277 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 317 318 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 318 319 310 311 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Class 1 PI3Kbeta was assayed as follows: PI3Kbeta (diluted in 50 mM Hepes, pH 7.5, 150 mM NaCl, 0.02% sodium cholate and 1 mM DTT) was assayed against PtdIns(4,5)P2-diC8 in a final volume of 50 mul containing 37 mM Hepes, pH 7.5, 111 mM NaCl, 0.02% sodium cholate, 5 mM DTT, 5 mM MgCl2, 1 mM ATP and 2 muM PtdIns(4,5)P2 and incubated for 70 min at room temperature. Assays were stopped by addition of 5.5 mul 50 mM EDTA and 25 mul assay mixture was transferred to Lumitrac 200 plate. Detection mix 1 was added to give a final volume of 50 mul and the mixture was incubated for 20 min at room temperature before reading.
###end p 25
###begin p 26
###xml 383 384 375 376 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 662 663 650 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Class 2 PI3KC2beta was assayed as follows: PI3KC2beta (diluted in 20 mM Tris/HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.5 mM EGTA and 0.02% CHAPS) was assayed against phosphoinositide substrate in a final volume of 50 mul containing 19 mM Tris/HCl, pH 7.5, 143 mM NaCl, 0.96 mM EDTA, 0.96 mM DTT, 0.48 mM EGTA, 0.02% CHAPS, 20 muM phosphatidylinositol, 0.2 mM ATP and 2 mM MgCl2 and incubated for 30 min at room temperature. Assays were stopped by addition of 5.5 mul 50 mM EDTA and 2% CHAPS, and 25 mul was transferred to Lumitrac 200 plate. Detection mix 2 (18.6 mM Tris/HCl, pH 7.5, 140 mM NaCl, 0.9 mM DTT, 0.02% CHAPS, 1.4 mug SGK PX, 0.06 muM PtdIns3P-biotin, 1.6 mug streptavidin-allophycocyanin and 0.64 mug/ml Eu chelate-labelled antibody) was added to give a final volume of 50 ml and incubated for 30 min at room temperature before reading.
###end p 26
###begin p 27
###xml 373 374 371 372 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Class 3 VPS34 was assayed as follows: VPS34 (diluted in 20 mM Tris/HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.5 mM EGTA and 0.02% CHAPS) was assayed against phosphoinositide substrate in a final volume of 50 mul containing 19 mM Tris/HCl, pH 7.5, 143 mM NaCl, 0.96 mM EDTA, 0.96 mM DTT, 0.48 mM EGTA, 0.02% CHAPS, 20 muM phosphatidylinositol, 0.2 mM ATP and 2 mM MnCl2 and incubated for 60 min at room temperature. Assays were stopped by addition of 5.5 mul 50 mM EDTA and 2% CHAPS and 25 mul was transferred to a Lumitrac 200 plate. Detection mix 2 was added to give a final volume of 50 ml and incubated for 30 min at room temperature before reading.
###end p 27
###begin title 28
mTOR complexes kinase assays
###end title 28
###begin p 29
###xml 764 765 755 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 863 865 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 968 970 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1038 1039 1027 1028 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
HEK-293 cells were freshly lysed in Hepes lysis buffer. Lysate (1-4 mg) was pre-cleared by incubating with 5-20 mul of Protein G-Sepharose conjugated to pre-immune IgG. The lysate extracts were then incubated with 5-20 mul of Protein G-Sepharose conjugated to 5-20 mug of either anti-Rictor or anti-Raptor antibody, or pre-immune IgG. All antibodies were covalently conjugated to Protein G-Sepharose. Immunoprecipitations were carried out for 1 h at 4 degreesC on a vibrating platform. The immunoprecipitates were washed four times with Hepes lysis buffer, followed by two washes with Hepes kinase buffer. For Raptor immunoprecipitates used for phosphorylating S6K1, for the initial two wash steps the buffer included 0.5 M NaCl to ensure optimal kinase activity [7]. GST-Akt1 was isolated from serum-deprived HEK-293 cells incubated with PI-103 (1 muM for 1 h) [24]. GST-S6K1 was purified from serum-deprived HEK-293 cells incubated with rapamycin (0.1 muM for 1 h) [25]. mTOR reactions were initiated by adding 0.1 mM ATP and 10 mM MgCl2 in the presence or absence of Ku-0063794 and GST-Akt1 (0.5 mug) or GST-S6K1 (0.5 mug). Reaction were carried out for 30 min at 30 degreesC on a vibrating platform and stopped by addition of SDS sample buffer. Reaction mixtures were then filtered through a 0.22-mum-pore-size Spin-X filter and samples were subjected to electrophoresis and immunoblot analysis.
###end p 29
###begin title 30
Kinase assays
###end title 30
###begin p 31
###xml 445 447 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 520 522 509 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 824 826 813 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
HEK-293 were lysed in Tris lysis buffer. In order to perform Akt and S6K assays, 500 mug of lysate was incubated with 5 mug of the corresponding antibody conjugated to Protein G-Sepharose. To perform SGK1 activity assays, 50 mug of transfected lysate was incubated with 5 mug of glutathione-Sepharose. All the incubations were performed for 1 h at 4 degreesC on a vibrating platform. Kinase activity was assayed exactly as described previously [35] using the Crosstide peptide (GRPRTSSFAEG) at 30 muM. Incorporation of [32P]phosphate into the peptide substrate was determined by applying the reaction mixture to P81 phosphocellulose paper and liquid-scintillation counting of radioactivity after washing the papers in phosphoric acid. One unit of activity was defined as that which catalysed the incorporation of 1 nmol of [32P]phosphate into the substrate.
###end p 31
###begin title 32
GST-pull down of transfected SGK1 for immunoblotting analysis
###end title 32
###begin p 33
At 36 h post-transfection, HEK-293 cells were lysed in Tris lysis buffer. Lysate (0.5 mg) was affinity-purified on glutathione-Sepharose. Incubations were carried out for 1 h at 4 degreesC on a vibrating platform. The resultant precipitates were then washed twice with Tris lysis buffer containing 0.5 M NaCl, followed by two washes with Buffer A. The immunoprecipitates were resuspended in 20 mul of sample buffer, filtered through a 0.22-mumpore-size Spin-X filter, and samples were subjected to electrophoresis and immunoblot analysis as described below.
###end p 33
###begin title 34
Immunoblotting
###end title 34
###begin p 35
###xml 463 474 <span type="species:ncbi:3704">horseradish</span>
Total cell lysate (5-20 mug) or immunoprecipitated samples were heated at 95 degreesC for 5 min in sample buffer, and subjected to PAGE and electrotransfer to nitrocellulose membrane. Membranes were blocked for 1 h in TBS-Tween buffer containing 10% (w/v) non-fat dried skimmed milk powder. The membranes were probed with the indicated antibodies in TBS-Tween containing 5% (w/v) skimmed milk or 5% (w/v) BSA for 16 h at 4 degreesC. Detection was performed using horseradish peroxidase-conjugated secondary antibodies and the enhanced chemiluminescence reagent.
###end p 35
###begin title 36
Cell growth
###end title 36
###begin p 37
###xml 59 60 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 117 123 <span type="species:ncbi:9913">bovine</span>
MEFs were seeded in 24-well plates (20000 cells per 1.91 cm2 well) and grown overnight in the presence of 10% foetal bovine serum. Cells were then treated in the presence or absence or rapamycin or Ku-0063794 and the medium was changed every 24 h with freshly dissolved inhibitors. Every 24 h of treatment, cells were washed once with PBS, and fixed in 4% (v/v) paraformaldehyde in PBS for 15 min. After washing once with water, the cells were stained with 0.1% Crystal Violet in 10% ethanol for 20 min and washed three times with water. Crystal Violet was extracted from cells with 0.5 ml of 10% (v/v) ethanoic (acetic) acid for 20 min. The eluate was then diluted 1:10 in water, and absorbance at 590 nm was quantified.
###end p 37
###begin title 38
Flow cytometric analysis of cell cycle distribution
###end title 38
###begin p 39
Adherent MEFs were harvested by trypsinization, washed once in PBS, and re-suspended in ice-cold aq. 70% (v/v) ethanol. Cells were washed twice in PBS plus 1% (w/v) BSA and stained for 20 min in PBS plus 0.1% (v/v) Triton X-100 containing 50 g/ml propidium iodide and 50 g/ml RNase A. The DNA content of cells was determined using a FACSCalibur flow cytometer (BD Biosciences) and CellQuest software. Red fluorescence (585+/-42 nm) was acquired on a linear scale, and pulse width analysis was used to exclude doublets. Cell-cycle distribution was determined using FlowJo software (Tree Star).
###end p 39
###begin title 40
RESULTS
###end title 40
###begin title 41
Ku-0063794 is a specific mTORC1 and mTORC2 inhibitor
###end title 41
###begin p 42
###xml 40 48 40 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 157 165 157 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 212 220 212 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 233 235 233 235 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 386 387 374 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 387 388 375 376 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 523 532 510 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figures 1</xref>
###xml 538 539 525 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 618 625 605 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 766 773 740 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 992 999 958 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
The structure of Ku-0063794 is shown in Figure 1(A). It inhibited the activity of endogenous immunoprecipitated mTORC1, assayed employing S6K1 as substrate (Figure 1B) and mTORC2, assayed using Akt as substrate (Figure 1C) with an IC50 of approximately10 nM. To evaluate the specificity of Ku-0063794, we studied the effect of Ku-0063794 at ATP concentrations, which approximate to the Km constant for ATP, towards a panel of 76 protein kinases. At 1 muM Ku-0063794, which completely suppressed mTORC1 and mTORC2 activity (Figures 1B and 1C), none of the kinases on the specificity panel were significantly inhibited (Table 1). Even at 10 muM, the only enzyme on the panel that was inhibited more than 2-fold was MAPK kinase-1, which was decreased approximately55% (Table 1). Ku-0063794, even at concentrations of 10 muM, did not significantly inhibit seven lipid kinases tested (Class I PI3Kalpha and PI3Kbeta, Class II PI3K-B, Class III VPS34 as well as SPHK-1, SPHK-2 and choline kinase) (Table 2).
###end p 42
###begin title 43
###xml 53 61 53 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Ku-0063794 inhibits both mTORC1 and mTORC2 complexes in vitro
###end title 43
###begin p 44
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 30 31 30 31 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 36 37 36 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 140 141 140 141 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 168 169 168 169 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 242 243 242 243 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 258 259 258 259 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 571 574 571 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">389</sup>
###xml 602 605 602 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
(A) Structure of Ku-0063794. (B and C) HEK-293 cell extracts were subjected to immunoprecipitation (IP) with pre-immune (IgG), anti-Raptor (B) or anti-Rictor antibody (C). The immunoprecipitates were incubated with dephosphorylated GST-S6K1 (B) or GST-Akt1 (C) in the presence of the indicated concentrations of Ku-0063794 or vehicle (DMSO). Kinases assays were performed for 30 min in the presence of MgATP and then subjected to immunoblot analysis with the indicated antibodies. Similar results were obtained in three independent experiments. T389-P, phosphorylated Thr389; S473-P, phosphorylated Ser473.
###end p 44
###begin title 45
Ku-0063794 inhibits mTORC1 activity in HEK-293 cells
###end title 45
###begin p 46
###xml 171 179 171 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 348 351 348 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">389</sup>
###xml 540 543 540 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">229</sup>
###xml 635 643 635 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 832 840 832 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1080 1088 1080 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1095 1103 1095 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1725 1733 1689 1697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1868 1876 1832 1840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
We next investigated the effect of adding increasing amounts of Ku-0063794 on the activity and phosphorylation of S6K1 in HEK-293 cells cultured in the presence of serum (Figure 2A). Under these conditions, with a concentration of Ku-0063794 as low as 30 nM, Ku-0063794 almost ablated S6K1 activity and phosphorylation of the hydrophobic motif (Thr389). Consistent with phosphorylation of the T-loop of S6K1 being dependent upon prior phosphorylation of the hydrophobic motif, Ku-0063794 inhibited phosphorylation of the T-loop residue (Thr229). Ku-0063794 also inhibited phosphorylation of the ribosomal S6 protein, an S6K substrate (Figure 2A). The ability of Ku-0063794 to suppress S6K1 activity and phosphorylation was rapid, with maximal inhibition seen within 10 min and sustained for at least 4 h, the longest time examined (Figure 2B). Ku-0063794 also suppressed S6K1 activity and phosphorylation induced by IGF1 stimulation of serum-starved HEK-293 cells, although higher concentrations were required to fully inhibit S6K1, compared with cells cultured in serum (compare Figure 2A with Figure 2C). For example, in the presence of serum, 30 nM Ku-0063794 suppressed S6K1 activity by approximately90%, whereas following IGF1 stimulation, 30 nM Ku-0063794 suppressed S6K1 activity by approximately50%. In the presence of IGF1, a concentration of 300 nM Ku-0063794 was necessary to reduce S6K1 activity approximately90%. mTORC1, and hence S6K1, is also activated by nutrients such as amino acids. We observed that Ku-0063794 induced a dose-dependent inhibition of the phosphorylation of S6K1 and S6 protein induced following the replenishment of amino acids to HEK-293 cells incubated in medium lacking these nutrients (Figure 2D). Concentrations of 100-300 nM Ku-0063794 were required to fully suppress amino-acid-induced phosphorylation of S6K1 and S6 protein (Figure 2D).
###end p 46
###begin title 47
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Ku-0063794 inhibits mTORC1 activity in vivo
###end title 47
###begin p 48
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 7 8 7 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 175 176 175 176 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 227 228 226 227 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 550 551 547 548 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 560 561 557 558 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 671 672 668 669 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 681 682 678 679 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 63 69 <span type="species:ncbi:9913">bovine</span>
(A and B) HEK-293 cells cultured in the presence of 10% foetal bovine serum, were treated for 30 min in the absence or presence of the indicated concentrations of Ku-0063794 (A) or with 1 muM Ku-0063794 for the indicated time (B). Cells were lysed and S6K1 immunoprecipitated and catalytic activity assessed employing the Crosstide substrate. Each bar represents the mean specific activity+/-S.E.M. from three different samples, with each sample assayed in duplicate. Cell lysates were also analysed by immunoblotting with the indicated antibodies. (C) As in (A), except that cells were deprived of serum for 16 h prior to stimulation with 50 ng/ml of IGF-1 for 20 min. (D) As in (C), except that, after 16 h of serum deprivation, cells were incubated for 1 h in amino-acid-free EBSS (Earle's Balanced Salt Solution) medium containing 10% dialysed serum. Cells were then incubated in the absence or presence or the indicated amount of Ku-0063794 for 30 min prior to re-addition of physiological levels of amino acids for an additional 30 min. Immunoblots are representative of three different experiments.
###end p 48
###begin title 49
Effect of Ku-0063794 on seven lipid kinases
###end title 49
###begin p 50
Results are presented as percentage of lipid kinase activity compared with control incubations in which Ku-0063794 was omitted. Lipid kinases were assayed as described in the Materials and methods section, in the absence or presence of the indicated concentration of Ku-0063794. The results are an average of a triplicate determinations+/-S.D.
###end p 50
###begin p 51
###xml 58 62 58 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2448</sup>
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 160 164 160 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2481</sup>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 237 241 237 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2448</sup>
###xml 249 253 249 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2481</sup>
###xml 334 347 334 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figures 2A&#8211;2C</xref>
Recent work has shown that mTORC1 is phosphorylated at Ser2448 [36], a reaction probably mediated by S6K1 [37,38]. In contrast, mTORC2 autophosphorylates at Ser2481 [36]. We observed that Ku-0063795 suppressed phosphorylation of both Ser2448 and Ser2481 in a dose-dependent and time-dependent manner, similar to S6K1 (lower panels of Figures 2A-2C).
###end p 51
###begin title 52
Ku-0063794 inhibits mTORC2 activity in HEK-293 cells
###end title 52
###begin p 53
###xml 118 121 118 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 183 191 183 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 225 233 225 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 333 336 333 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 548 556 548 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 563 571 563 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 656 664 644 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 671 679 659 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 957 966 945 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figures 3</xref>
###xml 972 973 960 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 1028 1031 1016 1019 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">246</sup>
###xml 1033 1035 1021 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 1063 1065 1044 1046 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">21</sup>
###xml 1069 1070 1050 1051 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 1072 1074 1053 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 1096 1098 1077 1079 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">24</sup>
###xml 1102 1104 1083 1085 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1106 1108 1087 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 1227 1235 1208 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1441 1449 1421 1429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1641 1649 1596 1604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1822 1830 1776 1784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1837 1845 1791 1799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
To investigate whether Ku-0063794 inhibited mTORC2, we studied how it affected Akt activity and hydrophobic motif (Ser473) phosphorylation in HEK-293 cells. In the presence of serum (Figure 3A) or following IGF1 stimulation (Figure 3B), Ku-0063794 caused a dose-dependent suppression of Akt activity, accompanied by inhibition of Ser473 phosphorylation. As observed with S6K1, the activity and phosphorylation of Akt was inhibited by lower concentrations of Ku-0063794 when cells were cultured in serum compared with stimulation with IGF1 (compare Figure 3A with Figure 3B). IGF1 induces a approximately6-fold greater activation of Akt than serum (compare Figure 3A with Figure 3B), which is likely to account for the higher concentrations of Ku-0063794 required to inhibit Akt and S6K in IGF1-stimulated cells compared with serum. The effects of Ku-0063794 on Akt activity and phosphorylation were observed within 10 min and were sustained for up to 48 h (Figures 3C and 3D). Phosphorylation of the Akt substrates PRAS40 at Thr246 [39], GSK3alpha/GSK3beta at Ser21/Ser9 [40] and Foxo-1/3a at Thr24/Thr32 [41] was also inhibited to a similar extent by Ku-0063794 as Akt activity and phosphorylation in cells cultured in serum (Figure 3A). In cells stimulated with IGF1, which induced a greater activation of Akt than observed with serum, even concentrations of 1 muM Ku-0063794 did not inhibit Akt phosphorylation and activation completely (Figure 3B). At 1 muM Ku-0063794 in IGF-1 stimulated cells, Akt1 activity was reduced to approximately0.5 units/mg, which is approximately50% of the Akt activity observed with cells cultured in serum (Figure 3A). This may explain why phosphorylation of GSK3 and Foxo are not completely suppressed with 1 muM Ku-00637954 in IGF1-stimulated compared with serum-treated cells (compare Figure 3A with Figure 3B).
###end p 53
###begin title 54
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Ku-0063794 ablates mTORC2 in vivo
###end title 54
###begin p 55
###xml 135 143 135 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 508 509 506 507 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
HEK-293 cells were cultured in serum, and stimulated with IGF-1 in the absence or presence of Ku-0063794 as described in the legend to Figure 2. Akt1 was immunoprecipitated and catalytic activity assessed employing the Crosstide substrate. Each bar represents the mean specific activity+/-S.E.M. from three different samples, with each sample assayed in duplicate. Cell lysates were analysed by immunoblotting with the indicated antibodies. Immunoblots are representative of three different experiments. In (D), medium containing freshly dissolved Ku-0063794 was replaced every 12 h. P, phosphorylated.
###end p 55
###begin p 56
###xml 68 71 68 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">450</sup>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 221 224 220 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">450</sup>
###xml 254 262 253 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 312 315 311 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">450</sup>
###xml 398 400 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 401 403 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
We also studied the effect that Ku-0063794 had on the turn-motif Thr450 residue of Akt1, whose phosphorylation is regulated by mTORC2 [26,27]. Even after 48 h treatment with 1 muM Ku-0063794, phosphorylation of Akt at Thr450 was only moderately reduced (Figure 3D). This is consistent with phosphorylation of Thr450 being introduced in Akt shortly after its synthesis and turning over very slowly [26,27].
###end p 56
###begin title 57
###xml 49 52 49 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
Ku-0063794 inhibits phosphorylation of Akt at Thr308 in HEK-293 cells
###end title 57
###begin p 58
###xml 51 54 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 123 126 123 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 128 141 128 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figures 3A&#8211;3D</xref>
###xml 228 231 228 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 312 315 312 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 368 369 368 369 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 436 437 436 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 437 438 437 438 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 577 578 576 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 578 579 577 578 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 592 600 591 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 661 664 660 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 754 757 753 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 901 904 900 903 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 974 977 973 976 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 1154 1157 1153 1156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 1159 1167 1158 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1222 1225 1221 1224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 1306 1314 1305 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1390 1393 1389 1392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 1438 1446 1437 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1534 1537 1533 1536 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 1591 1593 1590 1592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1596 1604 1595 1603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1615 1617 1614 1616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1620 1628 1619 1627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1641 1643 1640 1642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1646 1654 1645 1653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1724 1727 1723 1726 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 1740 1743 1739 1742 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 1772 1785 1771 1784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figures 4C&#8211;4E</xref>
###xml 1846 1849 1845 1848 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 1927 1930 1926 1929 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 1975 1988 1974 1987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figures 4C&#8211;4E</xref>
###xml 2071 2074 2070 2073 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
We observed that, in addition to inhibiting Akt Ser473 phosphorylation, Ku-0063794 suppressed phosphorylation of Akt at Thr308 (Figures 3A-3D). This was unexpected, as some previous work suggested that the phosphorylation of Thr308 by PDK1 is not directly influenced by mTORC2. Ku-0063794 was not suppressing Thr308 phosphorylation by inhibiting PI3K or PtdIns(3,4,5)P3 production, as IGF1 induced a similar enhancement of PtdIns(3,4,5)P3 levels in the absence or presence of 1 muM Ku-0063794, under conditions which the PI3K inhibitor PI-103 ablated IGF1-induced PtdIns(3,4,5)P3 production (Figure 4A). To further evaluate the effect that Ku-0063794 had on Thr308 phosphorylation, we overexpressed in HEK-293 cells a mutant form of GST-Akt1 in which Ser473 was changed to aspartate in an attempt to mimic the Akt-phosphorylated form of mTORC2 and tested how Ku-0063794 affected phosphorylation at Thr308. We found that IGF1-induced phosphorylation of GST-Akt1(S473D) at Thr308 was not suppressed by Ku-0063794 to the same extent as endogenous Akt in these cells, suggesting that Ku-0063794 is not directly inhibiting PDK1-mediated phosphorylation of Thr308 (Figure 4B). In parallel studies, Ku-0063794 also suppressed Thr308 phosphorylation of wild-type GST-Akt1 to a greater extent than GST-Akt1(S473D) (Figure 4B). The dual PI3K and mTOR inhibitor PI-103 inhibited phosphorylation of Thr308 on both GST-Akt1(S473D) and wild-type Akt1 (Figure 4B). We also examined the effect that Ku-0063794 had on the phosphorylation of Akt at Thr308 in MEFs lacking the critical mTORC2 subunits Rictor [29] (Figure 4C), mLST8 [17] (Figure 4D) and Sin1 [16] (Figure 4E). Consistent with previous work, IGF1 induced phosphorylation of Thr308, but not Ser473, in mTORC2-deficient cells (Figures 4C-4E). However, Ku-0063794 did not inhibit phosphorylation of Thr308 in any of the mTORC2-deficient cells under conditions where it suppressed Thr308 phosphorylation in control wild-type cells (Figures 4C-4E). Treatment of mTORC2-deficient cells with PI-103 abolished phosphorylation of Thr308.
###end p 58
###begin title 59
###xml 60 63 60 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
Further investigation of the effect of Ku-0063794 on Akt Thr308 phosphorylation
###end title 59
###begin p 60
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 281 282 281 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 282 283 282 283 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 373 374 371 372 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 628 629 626 627 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 780 781 778 779 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 782 783 780 781 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 946 947 944 945 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
(A) HEK-293 cells were deprived of serum for 16 h, treated for 30 min in the absence or presence of the indicated concentrations of Ku-0063794 or PI-103, then stimulated with 50 ng/ml of IGF-1 for 10 min. Cell were lysed with 0.5 M trichloroacetic acid and amounts of PtdIns(3,4,5)P3 were determined. Each bar represents the means+/-S.E.M. from three independent samples. (B) HEK-293 cells were transfected with a DNA construct encoding wild-type or mutant GST-Akt1. At 24 h post-transfection, cells were deprived of serum for 16 h and stimulated with IGF-1 for 20 min, in the presence or absence of inhibitors as described in (A). Cell lysates were analysed by immunoblotting with the indicated antibodies and immunoblots shown are representative of three separate experiments. (C-E) The indicated wild-type (wt) or knockout (ko) MEFs were deprived and stimulated with IGF-1 for 20 min, in the presence or absence of inhibitors as described in (A). Cell lysates were analysed by immunoblotting with the indicated antibodies. Similar results were obtained in three independent experiments. P, phosphorylated.
###end p 60
###begin title 61
Ku-0063794 inhibits SGK1 but not RSK
###end title 61
###begin p 62
###xml 82 85 82 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">422</sup>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 202 224 202 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caenorhabditis elegans</italic>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 590 598 590 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 661 664 661 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">422</sup>
###xml 761 769 761 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 921 923 921 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 1185 1193 1185 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1229 1237 1229 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1327 1329 1327 1329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 202 224 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 906 911 <span type="species:ncbi:10090">mouse</span>
We have shown that SGK1 activity and phosphorylation of its hydrophobic motif (Ser422) is regulated by mTORC2 but not mTORC1 [21]. This finding has recently been supported by elegant genetic studies in Caenorhabditis elegans [42,43]. SGK1 activity and hydrophobic motif phosphorylation should therefore be inhibited by Ku-0063794, but not rapamycin. As it is not possible to assay phosphorylation and activity of endogenous SGK1 [21], we investigated how Ku-0063794 affected activity and phosphorylation of overexpressed full-length SGK1 in HEK-293 cells cultured in the presence of serum (Figure 5A). We observed that Ku-0063794 inhibited SGK1 activity and Ser422 phosphorylation in a dose-dependent manner, to the same extent as Akt and S6K1 phosphorylation (Figure 5A). We also examined the phosphorylation of NDRG1, a well-characterized substrate for SGK1, which is not phosphorylated in SGK1 knockout mouse tissues [44]. Employing an antibody recognizing the SGK1-phosphorylated form of NDRG1, we found that Ku-0063794 inhibited NDRG1 phosphorylation to the same extent as it suppressed SGK1 activity. Phosphorylation of endogenous NDRG1 was also inhibited by Ku-0063794 in HeLa (Figure 5B) cells as well as wild-type MEFs (Figure 5C). The dual PI3K/mTOR inhibitor PI-103, but not rapamycin or the Akt inhibitor Akti-1/2 [45], reduced phosphorylation of NDRG1 in both HeLa cells and wild-type MEFs.
###end p 62
###begin title 63
Ku-0063794 suppresses hydrophobic motif phosphorylation and activation of SGK1 but not RSK
###end title 63
###begin p 64
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 731 734 729 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">422</sup>
###xml 860 861 858 859 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 866 867 864 865 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1233 1234 1231 1232 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 146 152 <span type="species:ncbi:9913">bovine</span>
(A) HEK-293 cells were transfected with a DNA construct encoding GST-SGK1 (full-length enzyme). Cells were cultured in the presence of 10% foetal bovine serum in order to maintain PI3K pathway activity. At 36 h post-transfection, cells were treated for 30 min in the absence or presence of the indicated concentrations of Ku-0063794 or PI-103. Cells were lysed, SGK1 was affinity-purified on glutathione-Sepharose and catalytic activity was assessed employing the Crosstide substrate. Each bar represents the mean specific activity+/-S.E.M. from three different samples, with each sample assayed in duplicate. Affinity purified SGK1 was also subjected to immunoblotting with an anti-GST antibody (SGK1-Total) as well as an anti-Ser422 phosphospecific antibody (S422-P). Cell lysates were also analysed by immunoblotting with the indicated non-SGK antibodies. (B and C) HeLa cells or the indicated wild-type (wt) or knockout (ko) MEFs were cultured in the presence of 10% serum, then treated for 30 min in the absence or presence of the indicated concentrations of inhibitors. Cells were lysed and extracts were analysed by immunoblotting with the indicated antibodies. Immunoblots are representative of three different experiments. (D) HEK-293 cells were deprived of serum for 16 h, treated for 30 min in the absence or presence of 1 muM Ku-0063794 or 0.2 muM PD 0325901 then stimulated with 400 ng/ml of PMA for 15 min. RSK was immunoprecipitated with an antibody recognizing all isoforms and catalytic activity assessed employing the Crosstide substrate. Each bar represents the mean specific activity+/-S.E.M. from two different samples, with each sample assayed in duplicate. Cell lysates were also analysed by immunoblotting with the indicated antibodies. P, phosphorylated.
###end p 64
###begin p 65
###xml 355 363 355 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 581 589 581 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
To ensure Ku-0063794 was not inhibiting the phosphorylation and activity of all AGC kinases, we studied the effect that Ku-0063794 had on the activation of the RSK, which is activated by ERK1/ERK2 pathway and not regulated by mTOR. HEK-293 cells were stimulated with phorbol ester, which markedly enhanced ERK as well as RSK phosphorylation and activity (Figure 5D). Ku-0063794 did not inhibit phorbol ester-induced ERK or RSK phosphorylation and RSK activation under conditions in which the MAPK kinase inhibitor PD 0325901-CL [46] ablated ERK phosphorylation and RSK activation (Figure 5D).
###end p 65
###begin title 66
Ku-0063794 induces complete dephosphorylation of 4E-BP1
###end title 66
###begin p 67
###xml 99 107 99 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 128 136 128 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 282 284 282 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">37</sup>
###xml 289 291 289 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">46</sup>
###xml 299 301 299 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">65</sup>
###xml 496 505 496 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figures 6</xref>
###xml 511 512 511 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
Consistent with mTOR regulating 4E-BP1 phosphorylation, we found that treatment of wild-type MEFs (Figure 6A) or HEK-293 cells (Figure 6B) with Ku-0063794 induced a marked increase in the electrophoretic mobility of 4E-BP1, which was accompanied by complete dephosphorylation of Thr37, Thr46 and Ser65. We observed that rapamycin reduced phosphorylation of 4E-BP1 and enhanced electrophoretic mobility to a significantly lower extent than Ku-0063794, even in mTORC2-deficient Sin1 knockout MEFs (Figures 6A and 6B).
###end p 67
###begin title 68
Ku-0063794 induces a marked dephosphorylation of 4E-BP1
###end title 68
###begin p 69
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 7 8 7 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 62 63 62 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 83 84 83 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
(A and B) The indicated wild-type (wt) or knockout (ko) MEFs (A) or HEK-293 cells (B) were cultured in the presence of 10% serum, and treated for 30 min in the absence or presence of the indicated concentrations of inhibitors. Cells were lysed and extracts analysed by immunoblotting with the indicated antibodies. Immunoblots are representative of three different experiments. P, phosphorylated.
###end p 69
###begin title 70
###xml 47 48 47 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Ku-0063794 suppresses cell growth and induces G1-cell cycle arrest
###end title 70
###begin p 71
###xml 420 428 420 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 452 460 452 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 588 596 588 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 624 632 624 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 643 644 643 644 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 747 748 747 748 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
We compared the effect that Ku-0063794 and rapamycin had on growth of wild-type and mLST8 deficient MEFs. We selected these cells, as despite lacking mTORC2, they proliferate at similar rates in serum as wild-type control fibroblasts. Moreover, mLST8-fibroblast cell lines proliferate more rapidly than Rictor- or Sin1-deficient MEFs (results not shown). We observed that Ku-0063794 suppressed growth of both wild-type (Figure 7A) and mLST8-deficient (Figure 7C) MEFs more markedly than rapamycin. Flow-cytometric analysis indicated that Ku-0063794 increased the proportion of wild-type (Figure 7B) and mLST8 knockout MEFs (Figure 7D) in the G1 cell cycle state approx. 2-fold, compared with rapamycin, which increased the proportion of cells in G1 by 1.5-fold.
###end p 71
###begin title 72
###xml 47 48 47 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Ku-0063794 inhibits cell growth and induces a G1 cell cycle arrest
###end title 72
###begin p 73
###xml 104 105 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 231 232 230 231 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 237 238 236 237 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 565 566 562 563 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 571 572 568 569 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 676 677 673 674 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 686 687 683 684 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 835 836 832 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 872 873 869 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The indicated wild-type (wt) or knockout (ko) MEFs were passaged at low density (20000 cells per 1.91 cm2 dish) and cells were cultured for 1, 2 or 3 days in the absence (DMSO) or presence of 3 muM Ku-0063794 or 100 nM rapamycin. (A and C) Cell numbers were measured in quadruplicate using a Crystal Violet staining as described in the Materials and methods section. The results are presented as means+/-S.E.M. of the percentage of cells relative to the DMSO control. Flow cytometric analysis was also undertaken as described in the Materials and methods section. (B and D) DNA was stained with propidium iodide, and cellular content was analysed. The percentage of cells in G1, S, or G2 phases were determined from triplicate dishes for each condition using CellQuest software. Two-way ANOVA and Bonferroni posttests were performed, *P<0.001 compared with DMSO control. #P<0.001 compared with rapamycin.
###end p 73
###begin title 74
DISCUSSION
###end title 74
###begin p 75
###xml 362 364 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 423 425 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 438 440 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 451 453 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 471 473 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 642 644 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 732 739 725 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 818 819 811 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 819 820 812 813 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 867 875 860 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 924 927 917 920 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 996 1009 989 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figures 4C&#8211;4E</xref>
###xml 1064 1065 1057 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1065 1066 1058 1059 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1085 1088 1078 1081 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
Our results from the present study establish that Ku-0063794 is a potent and highly specific inhibitor of mTOR as it does not significantly inhibit 76 other protein kinases tested as well as seven lipid kinases, including class 1a PI3Kalpha and PI3Kbeta. mTOR belongs to the PI3K-related kinases (PIKK) subgroup, as it possesses significant similarity to PI3Ks [47]. Many widely used PI3K inhibitors, including wortmannin [48], LY294002 [48], PI-103 [49] and NVP-BEZ235 [50], inhibit mTOR with a potency similar to that towards Class 1 PI3Ks. Recently, specific PI3K inhibitors have been described that do not inhibit mTOR, such as GDC-0941 [51]. Our results from the present study demonstrate that Ku-0063794 does not inhibit PI3K in vivo, as Ku-0063794 does not suppress increases in cellular levels of PtdIns(3,4,5)P3 following IGF-1 stimulation of HEK-293 cells (Figure 4A). Moreover, Ku-0063794 does not inhibit Akt Thr308 phosphorylation in three different mTORC2-deficient MEF cell lines (Figures 4C-4E) under conditions which PI-103 inhibited PtdIns(3,4,5)P3 production and Thr308 phosphorylation.
###end p 75
###begin p 76
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 636 643 633 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 689 691 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 930 932 927 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 945 947 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 1350 1352 1347 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
Two other mTOR specific inhibitors that do not inhibit PI3K have recently been described, namely PP242 [52] and Torin [53]. Although the chemical structure of Torin has thus far not been disclosed, the chemical structures of PP242 and Ku-0063794 are quite distinct. We have synthesized PP242 and compared its specificity with Ku-0063794 and observed that it is less selective. At 1 muM PP242, 22 of the 76 kinases tested were inhibited by >50%, whereas at 10 muM PP242, 46 out of the 76 kinases were inhibited (results available upon request from D.R.A.). In contrast, 10 muM Ku-0063794 only suppressed 1 out of 76 kinases over 2-fold (Table 1). Torin was reported to be highly selective [53]. The availability of chemically unrelated mTOR inhibitors will be useful in confirming specificity of physiological responses observed when using these reagents. Our findings using Ku-0063794 are similar to those reported for the PP242 [52] and Torin [53], as all three inhibitors reduced hydrophobic motif as well as T-loop phosphorylation of endogenous S6K as well as Akt. We also demonstrated Ku-0063794, but not rapamycin or Akti-1/2, inhibited phosphorylation and activation of SGK1 as well as its physiological substrate NDGR1. This is consistent with our findings that SGK1 is regulated by mTORC2 and not the mTORC1 inhibitor rapamycin (reviewed in [54]). We would expect Torin and PP242 to also inhibit SGK1 activation and phosphorylation.
###end p 76
###begin p 77
###xml 46 48 46 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 61 63 61 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 82 85 82 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 161 164 161 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 172 175 172 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 370 373 370 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 473 476 473 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 516 519 516 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 596 598 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 638 641 638 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 657 660 657 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 748 751 748 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 806 809 806 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 877 880 877 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 1109 1111 1109 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 1112 1114 1112 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 1138 1140 1138 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B61">61</xref>
###xml 1349 1352 1349 1352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 1460 1463 1460 1463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 1573 1576 1573 1576 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 1728 1731 1728 1731 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 1823 1826 1823 1826 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 2070 2073 2070 2073 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 2094 2097 2094 2097 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 2177 2180 2177 2180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 2357 2358 2357 2358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2358 2359 2358 2359 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 2443 2446 2443 2446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 2526 2528 2514 2516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B62">62</xref>
###xml 2710 2713 2698 2701 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 2715 2717 2703 2705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 2754 2757 2742 2745 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 2877 2878 2865 2866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2878 2879 2866 2867 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 2914 2917 2902 2905 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 3044 3047 3032 3035 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 3123 3125 3111 3113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B63">63</xref>
###xml 3126 3128 3114 3116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B64">64</xref>
###xml 568 573 <span type="species:ncbi:10090">mouse</span>
###xml 1123 1128 <span type="species:ncbi:10090">mouse</span>
###xml 2284 2288 <span type="species:ncbi:10090">mice</span>
The finding that Ku-0063794 as well as Torin [53] and PP242 [52] inhibited Akt Thr308 phosphorylation is arguably unexpected, as previous work suggested that Thr308 and Ser473 phosphorylation can occur independently from each other. The initial evidence for this was that an Akt-T308A mutant overexpressed in IGF1-stimulated HEK-293 cells was still phosphorylated at Ser473 and vice versa [55]. Moreover, in cells lacking mTORC2 activity, Akt is still phosphorylated at Thr308 despite not being phosphorylated at Ser473 [16,17,29]. In PDK1-deficient cells [56] and in mouse tissues lacking PDK1 [57,58], Akt is still phosphorylated at Ser473, but not at Thr308. One explanation for the effect that mTOR inhibitors such as Ku-0063794 have on Akt Thr308 phosphorylation would be if Akt phosphorylation of Ser473 generated a docking site for PDK1 to interact and phosphorylate Thr308, in the same way in which phosphorylation of the hydrophobic motifs of S6K/SGK by mTOR promotes T-loop phosphorylation of these enzymes by PDK1. The evidence against this stems from previous studies undertaken in knockin cells [59,60] and in mouse tissues [61] that express a PIF-pocket mutant form of PDK1 that is unable to interact with the hydrophobic motifs of S6K and SGK1. In these knockin studies, it was demonstrated that Akt was normally phosphorylated at Thr308, under conditions which S6K and SGK are not phosphorylated at their T-loop residue, suggesting that Akt Thr308 phosphorylation was not dependent on PDK1 interacting with Akt via its PIF-pocket. How can the effects on Thr308 phosphorylation in mTOR inhibitor and knockin/knockout studies be reconciled? One possibility is that in wild-type cells, phosphorylation of Akt at Ser473 does indeed promote PDK1 interaction and contributes towards maximal phosphorylation of Thr308 by PDK1. However, in knockout cells permanently lacking mTORC2 activity or in PDK1 PIF-pocket mutant knockin cells, Akt activation may be so essential for survival that signalling networks adapt so that Akt can be phosphorylated by PDK1 at Thr308 independently of Ser473 phosphorylation. Evidence to support the idea that PDK1 might interact with Ser473 after its phosphorylation by mTORC2 might stem from recent observations made in PDK1-PH domain knockin mice that express a form of PDK1 that can not interact with PtdIns(3,4,5)P3. In tissues or cells derived from these animals, Akt is still phosphorylated at Thr308, albeit to approximately3-fold lower level than in wild-type tissues or cells [62]. This observation was unexpected, as previous evidence indicated that PDK1 was needed to interact with phosphoinositides at the plasma membrane in order to phosphorylate Akt at Thr308 [19]. However, if phosphorylation at Ser473 by mTORC2 does stimulate interaction of PDK1 with Akt, this may bypass the need for PDK1 to interact with PtdIns(3,4,5)P3 and enhance phosphorylation of Thr308 without the need of PDK1 binding to phosphoinositides. In future work, it would important to investigate the effect on Akt Thr308 phosphorylation of allosteric PIF-pocket PDK1 inhibitors being elaborated [63,64] or mTORC2-specific inhibitors (if such compounds could be developed).
###end p 77
###begin p 78
###xml 75 78 75 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 120 123 120 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 207 210 207 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B65">65</xref>
###xml 653 656 653 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 727 730 727 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 916 919 916 919 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 1009 1012 1009 1012 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 1100 1103 1100 1103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
Another possibility to account for the effect of mTOR inhibitors on Akt Thr308 phosphorylation is if the lack of Akt Ser473 phosphorylation leads to destabilization of Akt, promoting dephosphorylation of Thr308 by protein phosphatase(s). Indeed, this idea is supported by structural analysis of Akt2, where it has been demonstrated that hydrophobic motif phosphorylation induces a marked disorder-to-order transition of the kinase domain, resulting in stabilization of the alphaC helix with concomitant restructuring of the T-loop and reconfiguration of the structure of the catalytic domain [65]. Treatment of cells with Ku-0063794 will inhibit Akt Ser473 phosphorylation and may lead to less stable Akt conformation, with Thr308 being more exposed and accessible to becoming dephosphorylated by protein phosphatase(s). It would be interesting to investigate whether in mTORC2-deficient knockout cells, in which Thr308 phosphorylation is unaffected, the activity of the protein phosphatase(s) that act on Thr308 is reduced, or if Akt is stabilized in some way that enables it to function without Ser473 phosphorylation.
###end p 78
###begin p 79
###xml 12 20 12 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 41 43 41 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 56 58 56 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 432 434 432 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">37</sup>
###xml 438 440 438 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">46</sup>
###xml 448 450 448 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">65</sup>
###xml 835 837 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 850 852 850 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 1217 1230 1217 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figures 7C&#8211;7D</xref>
Ku-0063794 (Figure 6), as well as Torin [53] and PP242 [52], induce a much greater dephosphorylation of 4E-BP1 than rapamycin, suggesting that these drugs will more effectively suppress protein synthesis resulting from overactivation of the PI3K/Akt pathways. Both mTORC1 and mTORC2 activity would be inhibited in mTORC2-deficient cells treated with rapamycin. However, we still observed significant phosphorylation of 4E-BP1 at Thr37/Thr46 and Ser65 in Sin-1 knockout MEFs treated with rapamycin, under conditions in which the hydrophobic motif of both S6K and Akt are not phosphorylated (in agreement with lack of mTORC1 and mTORC2 activity). In contrast, treatment of Sin-1 knockout MEFs with Ku-0063794 led to a much greater dephosphorylation of 4E-BP1 than observed with rapamycin. Similar results were also found with the Torin [53] and PP242 [52] inhibitors. Taken together, these results indicate that rapamycin may not inhibit the phosphorylation of 4E-BP1 by mTORC1 and/or there may be a rapamycin-resistant form of mTOR, distinct from mTORC2. The existence of such a complex might also explain why Ku-0063794 inhibits proliferation of mTORC2-deficient mLST8 knockout cells more effectively than rapamycin (Figures 7C-7D). It would be interesting to see whether it might be possible to isolate a form of mTOR capable of phosphorylating 4E-BP1, which was inhibited by Ku-0063794, but not by rapamycin.
###end p 79
###begin p 80
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B66">66</xref>
###xml 200 205 <span type="species:ncbi:9606">human</span>
There is great expectation that inhibitors of the PI3K-PDK1-Akt-mTOR signalling axis will have utility as anti-cancer drugs, as this signalling network is inappropriately activated in the majority of human cancers. Rapamycin and its analogues are being extensively deployed for the treatment of various cancers [66]. It will be interesting to evaluate whether an inhibitor such as Ku-0063794, which targets both mTOR complexes, is a more effective anti-cancer agent than rapamycin. This might be expected, as mTOR inhibitors such as Ku-0063794, unlike rapamycin derivatives, will inhibit Akt and SGK isoforms that are likely to play vital roles in driving the proliferation of many cancers. The finding that mTOR inhibitors such as Ku-0063794 induce more marked dephosphorylation of 4E-BP1 than rapamycin also holds promise that these drugs will be more effective at suppressing protein synthesis required for growth and proliferation of cancer cells than rapamycin derivatives. Ku-0063794 and other mTOR inhibitors will also be very useful reagents to dissect and validate the molecular roles that mTOR plays and hence extend our repertoire of knowledge of how this master regulator of cell growth operates.
###end p 80
###begin title 81
AUTHOR CONTRIBUTION
###end title 81
###begin p 82
###xml 311 312 311 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 312 313 312 313 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 232 240 <span type="species:ncbi:39367">Rosemary</span>
Juan M. Garcia-Martinez, Sabina C. Cosulich, Christine M. Chresta and Dario R. Alessi planned and analysed experimental data. Juan M. Garcia-Martinez undertook most of the experimentation. Jennifer Moran undertook kinase profiling, Rosemary G. Clarke undertook FACS analysis and Alex Gray measured PtdIns(3,4,5)P3 levels. Sabina C. Cosulich and Christine M. Chresta were involved in the development of Ku-0063794. Juan M. Garcia-Martinez and Dario R. Alessi wrote the manuscript.
###end p 82
###begin title 83
ACKNOWLEDGEMENTS
###end title 83
###begin p 84
We thank Mark Magnuson, David Sabatini, and Bing Su for provision of reagents. We are also grateful to the Sequencing Service for DNA sequencing, the Post Genomics and Molecular Interactions Centre for Mass Spectrometry facilities (School of Life Sciences, University of Dundee, Dundee, Scotland, U.K.) and the protein production and antibody purification teams [Division of Signal Transduction Therapy (DSTT), University of Dundee, Dundee, Scotland, U.K.] co-ordinated by Hilary McLauchlan and James Hastie for expression and purification of antibodies.
###end p 84
###begin title 85
FUNDING
###end title 85
###begin p 86
###xml 38 49 38 49 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="gs1">AstraZeneca</funding-source>
###xml 69 115 69 115 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="gs2">Medical Research Council for financial support</funding-source>
J. M. G. M. is funded by a grant from AstraZeneca. We also thank the Medical Research Council for financial support.
###end p 86
###begin article-title 87
TOR signaling in growth and metabolism
###end article-title 87
###begin article-title 88
Growing roles for the mTOR pathway
###end article-title 88
###begin article-title 89
Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control
###end article-title 89
###begin article-title 90
Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action
###end article-title 90
###begin article-title 91
mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery
###end article-title 91
###begin article-title 92
Upstream and downstream of mTOR
###end article-title 92
###begin article-title 93
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase
###end article-title 93
###begin article-title 94
Bidirectional transport of amino acids regulates mTOR and autophagy
###end article-title 94
###begin article-title 95
The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1
###end article-title 95
###begin article-title 96
Regulation of TORC1 by Rag GTPases in nutrient response
###end article-title 96
###begin article-title 97
LKB1-dependent signaling pathways
###end article-title 97
###begin article-title 98
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
###end article-title 98
###begin article-title 99
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
###end article-title 99
###begin article-title 100
Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity
###end article-title 100
###begin article-title 101
mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s
###end article-title 101
###begin article-title 102
SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity
###end article-title 102
###begin article-title 103
###xml 12 16 <span type="species:ncbi:10090">mice</span>
Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1
###end article-title 103
###begin article-title 104
Identification of Protor as a novel Rictor-binding component of mTOR complex-2
###end article-title 104
###begin article-title 105
PDK1, the master regulator of AGC kinase signal transduction
###end article-title 105
###begin article-title 106
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
###end article-title 106
###begin article-title 107
mTOR complex-2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum and glucocorticoid induced protein kinase-1 (SGK1)
###end article-title 107
###begin article-title 108
Mammalian TOR controls one of two kinase pathways acting upon nPKCdelta and nPKCepsilon
###end article-title 108
###begin article-title 109
Phosphoinositide-dependent protein kinase 1, a sensor of protein conformation
###end article-title 109
###begin article-title 110
###xml 98 108 98 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 98 108 <span type="species:ncbi:7227">Drosophila</span>
3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase
###end article-title 110
###begin article-title 111
###xml 100 107 100 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 112 120 112 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro
###end article-title 111
###begin article-title 112
The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C
###end article-title 112
###begin article-title 113
Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling
###end article-title 113
###begin article-title 114
Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism
###end article-title 114
###begin article-title 115
J
###end article-title 115
###begin article-title 116
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability
###end article-title 116
###begin article-title 117
###xml 227 234 227 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Molecular basis for the substrate specificity of NIMA-related kinase-6 (NEK6). Evidence that NEK6 does not phosphorylate the hydrophobic motif of ribosomal S6 protein kinase and serum- and glucocorticoid-induced protein kinase in vivo
###end article-title 117
###begin article-title 118
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
in vivo role of the phosphate-binding groove of PDK1 defined by knockin mutation
###end article-title 118
###begin article-title 119
###xml 110 115 <span type="species:ncbi:9606">human</span>
High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells
###end article-title 119
###begin article-title 120
Nonradioactive methods for the assay of phosphoinositide 3-kinases and phosphoinositide phosphatases and selective detection of signaling lipids in cell and tissue extracts
###end article-title 120
###begin article-title 121
The selectivity of protein kinase inhibitors: a further update
###end article-title 121
###begin article-title 122
Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3- phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2
###end article-title 122
###begin article-title 123
TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2
###end article-title 123
###begin article-title 124
Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase
###end article-title 124
###begin article-title 125
Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase
###end article-title 125
###begin article-title 126
Identification of a proline-rich Akt substrate as a 14-3-3 binding partner
###end article-title 126
###begin article-title 127
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
###end article-title 127
###begin article-title 128
Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
###end article-title 128
###begin article-title 129
###xml 23 45 23 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caenorhabditis elegans</italic>
###xml 23 45 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Rictor/TORC2 regulates Caenorhabditis elegans fat storage, body size, and development through sgk-1
###end article-title 129
###begin article-title 130
###xml 73 95 73 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caenorhabditis elegans</italic>
###xml 73 95 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans
###end article-title 130
###begin article-title 131
Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3
###end article-title 131
###begin article-title 132
Use of Akt inhibitor and a drug-resistant mutant validates a critical role for protein kinase B/Akt in the insulin-dependent regulation of glucose and system A amino acid uptake
###end article-title 132
###begin article-title 133
The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901
###end article-title 133
###begin article-title 134
###xml 37 42 <span type="species:ncbi:9606">human</span>
The protein kinase complement of the human genome
###end article-title 134
###begin article-title 135
Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002
###end article-title 135
###begin article-title 136
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma
###end article-title 136
###begin article-title 137
###xml 161 168 161 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
###end article-title 137
###begin article-title 138
###xml 26 27 26 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</italic>
###xml 114 115 114 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</italic>
The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin -4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer
###end article-title 138
###begin article-title 139
Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2
###end article-title 139
###begin article-title 140
An ATP-competitive mTOR inhibitor reveals rapamycin-insensitive functions of mTORC1
###end article-title 140
###begin article-title 141
New insights into mTOR Signaling: mTORC2 and beyond
###end article-title 141
###begin article-title 142
Mechanism of activation of protein kinase B by insulin and IGF-1
###end article-title 142
###begin article-title 143
The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells
###end article-title 143
###begin article-title 144
Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia
###end article-title 144
###begin article-title 145
Deficiency of PDK1 in liver results in glucose intolerance, impairment of insulin-regulated gene expression and liver failure
###end article-title 145
###begin article-title 146
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
in vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation
###end article-title 146
###begin article-title 147
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
in vivo role of the phosphate groove of PDK1 defined by knockin mutation
###end article-title 147
###begin article-title 148
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Evaluation of approaches to generate PDK1 tissue specific knock-in mice
###end article-title 148
###begin article-title 149
Mutation of the PDK1 PH domain inhibits protein kinase B/Akt, leading to small size and insulin resistance
###end article-title 149
###begin article-title 150
Identification of allosteric PIF-pocket ligands for PDK1 using NMR-based fragment screening and 1H-15N TROSY experiments
###end article-title 150
###begin article-title 151
Allosteric activation of the protein kinase PDK1 with low molecular weight compounds
###end article-title 151
###begin article-title 152
Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation
###end article-title 152
###begin article-title 153
mTOR pathway and mTOR inhibitors as agents for cancer therapy
###end article-title 153

